A controlled trial of erythromycin and UDCA in premature infants during parenteral nutrition in minimizing feeding intolerance and liver function abnormalities

Journal of Perinatology

Volumn 32, Issue 2, 2012, Pages 123-128

  Gokmen, T ^a   Oguz, S S ^a   Bozdag, S ^a   Erdeve, O ^a   Uras, N ^a   Dilmen, U ^a  

^a Zekai Tahir Burak Maternity and Teaching Hospital   (Turkey)

Author keywords

cholestasis; erythromycin; feeding intolerance; preterm; ursodeoxycholic acid

Indexed keywords

ERYTHROMYCIN; GAMMA GLUTAMYLTRANSFERASE; PLACEBO; URSODEOXYCHOLIC ACID;

ARTICLE; BIRTH WEIGHT; BRAIN HEMORRHAGE; CHILD NUTRITION; CHOLESTASIS; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ENTEROPATHY; FEMALE; GESTATIONAL AGE; HUMAN; INTESTINAL FAILURE ASSOCIATED LIVER DISEASE; LENGTH OF STAY; LIVER DYSFUNCTION; LIVER FUNCTION TEST; LUNG DYSPLASIA; MALE; NECROTIZING ENTEROCOLITIS; NUTRITIONAL INTOLERANCE; OUTCOME ASSESSMENT; PARENTERAL NUTRITION; PATENT DUCTUS ARTERIOSUS; PREMATURITY; RANDOMIZED CONTROLLED TRIAL; SEPTICEMIA;

ADMINISTRATION, ORAL; CHILD DEVELOPMENT; CHOLESTASIS; DOUBLE-BLIND METHOD; EATING DISORDERS; ERYTHROMYCIN; FEEDING BEHAVIOR; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; INTENSIVE CARE UNITS, NEONATAL; LIVER DISEASES; LIVER FUNCTION TESTS; MALE; PARENTERAL NUTRITION; PROSPECTIVE STUDIES; RISK ASSESSMENT; URSODEOXYCHOLIC ACID; WEIGHT GAIN;

EID: 84856596542     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2011.56     Document Type: Article

References (26)

1. Kaufman SS, Gondolesi GE, Fishbein TM. Parenteral nutrition associated liver disease. Semin Neonatal 2003; 8(5): 375-381. (Pubitemid 37237133)
2. Titelbaum DH. Parenteral nutrition-associated cholestasis. Curr Opin Pediatr 1997; 9(3): 270-275.
3. Al Tawil Y, Berseth CL. Gestational and postnatal maturation of duodenal motor responses to intragastric feeding. J Pediatr 1996; 129(3): 374-381. (Pubitemid 27484143)
4. Peeters TL, Vantrappen G, Janssens J. Fasting plasma motilin levels are related to the interdigestive motility complex. Gastroenterology 1980; 79(4): 716-719. (Pubitemid 10009563)
5. Peeters TL, Depoortere T, Macielag M, Dharanipragada R, Marvin MS, Florance JR et al. The motilin antagonist ANQ-11125 blocks motilide-induced contractions in vitro in the rabbit. Biochem Biophys Res Commun 1994; 198: 411-416. (Pubitemid 24178383)
6. Peeters TL, Mattijs G, De poortere I, Cachet T, Hoogmartens J, Vantrappen G. Erythromycin is a motilin receptor agonist. Am J Physiol 1989; 257(3): 470-474.
7. James OF. Ursodeoxycholic acid treatment for chronic cholestatic liver disease. J Hepatol 1990; 11(1): 5-8. (Pubitemid 20250819)
8. Kowdley KV. Ursodeoxycholic acid therapy in hepatobiliary disease. Am J Med 2000; 108(8): 481-486. (Pubitemid 30214200)
9. Kumar D, Tandon RK. Use of ursodeoxycholic acid in liver diseases. J Gastroenterol Hepatol 2001; 16(1): 3-14. (Pubitemid 32120928)
10. Levine A, Maayan A, Shamir R, Dinari G, Sulkes J, Sirotta L. Parenteral nutrition-associated cholestasis in preterm neonates: evaluation of ursodeoxycholic acid treatment. J Pediatr Endocrinol Metab 1999; 12(4): 549-553. (Pubitemid 29334735)
11. Chen CY, Tsao PN, Chen HL, Chou HC, Hsieh WS, Chang MH. Ursodeoxycholic acid (UDCA) therapy in very-low-birth-weight infants with parenteral nutrition associated cholestasis. J Pediatr 2004; 145(3): 317-321.
12. Annese V, Janssens J, Vantrappen G, Tack J, Peeters TL, Willemse P et al. Erythromycin accelerates gastric emptying by inducing antral contractions and improved gastro-duodenal coordination. Gastroenterology 1992; 102(3): 823-828.
13. Costalos C, Gounaris A, Varhalama E, Kokari F, Alexiou N, Kolovou E. Erythromycin as a prokinetic agent preterm infants. J Pediatr Gastroenterol Nutr 2002; 34(1): 23-25. (Pubitemid 34251696)
14. Ng PC, Lee CH, Wong SPS, Lam HS, Liu FYB, So KW et al. High-dose oral erythromycin decreased the incidence of parenteral nutrition-associated cholestasis in preterm infants. Gastroenterology 2007; 132(5): 1726-1739. (Pubitemid 46677952)
15. Kleinman RE, Sandler RH. Cholestasis associated with parenteral nutrition. In: Walker WA, Durie PR, Hamilton JR, Walker-Smith JA, Watkins JB (eds). Pediatric Gastrointestinal Disease, vol. 2(17). People's Medical Publishing House: BC Dexter Inc, USA, 1996, pp 1271-1281.
16. Teitelbaum DH. Parenteral nutrition-associated cholestasis. Curr Opin Pediatr 1997; 9(3): 270-275. (Pubitemid 27336929)
17. Duerksen DR, Van Aerde JE, Gramlich L, Meddings JB, Chan G, Thomson AB et al. Intravenous ursodeoxycholic acid reduces cholestasis in parenterally fed newborn piglets. Gastroenterology 1996; 111(4): 1111-1117. (Pubitemid 26327615)
18. Lindor KD, Burnes J. Ursodeoxycholic acid for the treatment of home parenteral nutrition-associated cholestasis: a case report. Gastroenterology 1991; 101(1): 250-253.
19. Spagnuolo MI, lorio R, Vegnente A, Guarino A. Ursodeoxycholic acid for treatment of cholestasis in children on long term parenteral nutrition: a pilot study. Gastroenterology 1996; 111(3): 716-719. (Pubitemid 26293237)
20. Al-Hathlol K, Al-Madani A, Al-Saif S, Abulaimoun B, Al-Tawil K, El-Demerdash A. Ursodeoxycholic acid therapy for intractable total parenteral nutrition-associated cholestasis in surgical very low birth weight infants. Singapore Med J 2006; 47(2): 147-151. (Pubitemid 43189383)
21. Arslanoglu S, Moro GE, Tauschel HD, Boehm G. Ursodeoxycholic acid treatment in preterm infants: a pilot study for the prevention of cholestasis associated with total parenteral nutrition. J Pediatr Gastroenterol Nutr 2008; 46(2): 228-231. (Pubitemid 351161137)
22. Moss DW, Henderson AR. Clinical enzymology. In: Burtis CA, Ashwood ER (eds). Tietz Textbook of Clinical Chemistry. WB Saunders: Philadelphia, 1999, pp 686-689.
23. Ng SC, Gomez JM, Rajadurai VS, Saw SM, Quak SH. Establishing enteral feeding in preterm infants with feeing intolerance: a randomized controlled study of low-dose erythromycin. J Pediatr Gastroenterol Nutr 2003; 37(5): 554-558. (Pubitemid 39280860)
24. Nuntnarumit P, Kiatchoosakun P, Tantiprapa W, Boonkasidecha S. Efficacy of oral erythromycin for treatment of feeding intolerance in preterm infants. J Pediatr 2006; 148(5): 600-605. (Pubitemid 43776898)
25. Aly H, Abdel-Hady H, Khashaba M, El-Badry N. Erythromycin and feeding intolerance in premature infants: a randomized trial. J Perinatol 2007; 27(1): 39-43. (Pubitemid 44971051)
26. Ng PC, So KW, Fung KS, Lee CH, Fok TF, Wong W et al. Randominesed controlled study of oral erythromycin for treatment of gastrointestinal dysmotility in preterm infants. Arch Dis Child Fetal Neonatal Ed 2001; 84(3): 177-182.